# FDA Inspection 1074349 - Intas Pharmaceuticals Limited - December 14, 2018

Source: https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/9fbc901d-b132-4d7d-9fdf-8ac222f2fec6
Source feed: FDA_Inspections

> FDA Inspection 1074349 for Intas Pharmaceuticals Limited on December 14, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1074349
- Company Name: Intas Pharmaceuticals Limited
- Inspection Date: 2018-12-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1245599 - 2024-07-12](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/b7786616-f193-421d-81ca-40e09d86547d)
- [FDA Inspection 1098380 - 2019-08-02](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/0895eb6a-065a-49a6-ac84-da712eda4358)
- [FDA Inspection 1056170 - 2018-06-08](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/40778dca-3416-4505-9b4f-98131521219b)
- [FDA Inspection 978469 - 2016-06-17](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/3aaf3f2a-46fc-4904-a72f-b656172dc11e)
- [FDA Inspection 923354 - 2015-04-07](https://www.keypedia.com/records/fda_inspections/intas-pharmaceuticals-limited/493332f9-a20f-4012-b808-81c974265ac5)

Company: https://www.keypedia.com/companies/intas-pharmaceuticals-limited/0db00702-d7f6-4a8b-87d1-1b32ac236cc8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c